 
		
					Colon cancer DNA may guide tailored post-surgery care
Circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—may help risk-stratify patients with Stage 3 colon cancer by tailoring chemotherapy options after surgery based on risk of cancer recurrence, according to new research […]

 
		 
		 
		 
		 
		 
		 
		 
		